Janssen Pharmaceutical Companies of Johnson & Johnson to Exhibit at 2011 BIO International Convention, June 27 - 30, 2011

TITUSVILLE, N.J.--(BUSINESS WIRE)-- Press Kit Materials are Available at: http://www.tradeshownews.com/events/2011-BIO-International-Convention/janssen/


  Janssen Pharmaceutical Companies of Johnson & Johnson

2011 BIO International Convention
June 27 - 30, 2011
Washington DC, US



About Janssen Pharmaceutical Companies of Johnson & Johnson

The Janssen Pharmaceutical Companies are dedicated to addressing and solving the most important unmet medical needs of our time. Our people, across many different companies, are united in their passionate pursuit of science for the benefit of patients. With employees in over 50 countries, we are working to bring innovative ideas, products and services to patients throughout the world.


PR Contact
Porter Novelli
Virginia Amann, 608-207-0082
[email protected]

KEYWORDS:   United States  North America  District of Columbia  New Jersey

INDUSTRY KEYWORDS:   Health  Biotechnology  Pharmaceutical  Other Health


Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.